Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 106, Issue 4
May 2018
Issue Cover
All Issues
ISSN 0028-3835
EISSN 1423-0194
In this Issue

Neuroendocrinology 2018, Vol. 106, No. 4

Original Paper

Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update
Emilio Bajetta; Laura Catena; Sara Pusceddu; Francesca Spada; Claudio Iannacone; Italo Sarno; Giandomenico Di Menna; Lorenzo Dottorini; Anna Maria Marte
Neuroendocrinology (2018) 106 (4): 307–311. https://doi.org/10.1159/000479587
View articletitled, Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update
Open the PDF for in another window
Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine
Anna E. Heverhagen; Nathalie Legrand; Vinona Wagner; Volker Fendrich; Detlef K. Bartsch; Emily P. Slater
Neuroendocrinology (2018) 106 (4): 312–317. https://doi.org/10.1159/000480121
View articletitled, Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine
Open the PDF for in another window
Safety and Efficacy of the S-1/Temozolomide Regimen in Patients with Metastatic Neuroendocrine Tumors
Jiuda Zhao; Hong Zhao; Yihebali Chi
Neuroendocrinology (2018) 106 (4): 318–323. https://doi.org/10.1159/000480402
View articletitled, Safety and Efficacy of the S-1/Temozolomide Regimen in Patients with Metastatic Neuroendocrine Tumors
Open the PDF for in another window
Role of Oxytocin in Prolactin Secretion during Late Pregnancy
Carlos M. Villegas-Gabutti; Gisela E. Pennacchio; Laura Vivas; Graciela A. Jahn; Marta Soaje
Neuroendocrinology (2018) 106 (4): 324–334. https://doi.org/10.1159/000480669
View articletitled, Role of Oxytocin in Prolactin Secretion during Late Pregnancy
Open the PDF for in another window
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors
Elke Tatjana Aristizabal Prada; Carla Weis; Michael Orth; Michael Lauseker; Gerald Spöttl; Julian Maurer; Patricia Grabowski; Ashley Grossman; Christoph Josef Auernhammer; Svenja Nölting
Neuroendocrinology (2018) 106 (4): 335–351. https://doi.org/10.1159/000481887
View articletitled, GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors
Open the PDF for in another window

At the Cutting Edge

Gut Microbiota and Host Metabolism: What Relationship
Gilles Mithieux
Neuroendocrinology (2018) 106 (4): 352–356. https://doi.org/10.1159/000484526
View articletitled, Gut Microbiota and Host Metabolism: What Relationship
Open the PDF for in another window
The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines
Wouter T. Zandee; Wouter W. de Herder
Neuroendocrinology (2018) 106 (4): 357–365. https://doi.org/10.1159/000486096
View articletitled, The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines
Open the PDF for in another window

Original Paper

Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia
Faidon Marios Laskaratos; Leonidas Diamantopoulos; Martin Walker; Henry Walton; Mohamed Khalifa; Fatima El-Khouly; Apostolos Koffas; George Demetriou; Martyn Caplin; Christos Toumpanakis; Dalvinder Mandair
Neuroendocrinology (2018) 106 (4): 366–380. https://doi.org/10.1159/000486097
View articletitled, Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia
Open the PDF for in another window
Extremely Long Survival under Combined Immunotherapy in a Metastatic Functional Neuroendocrine Neoplasia Patient
Daniel Schmidt; Bertram Wiedenmann
Neuroendocrinology (2018) 106 (4): 381–388. https://doi.org/10.1159/000486417
View articletitled, Extremely Long Survival under Combined Immunotherapy in a Metastatic Functional Neuroendocrine Neoplasia Patient
Open the PDF for in another window
The Role of Central Androgen Receptor Actions in Regulating the Hypothalamic-Pituitary-Ovarian Axis
Kirsty A. Walters; Melissa C. Edwards; Dijana Tesic; Aimee S.L. Caldwell; Mark Jimenez; Jeremy T. Smith; David J. Handelsman
Neuroendocrinology (2018) 106 (4): 389–400. https://doi.org/10.1159/000487762
View articletitled, The Role of Central Androgen Receptor Actions in Regulating the Hypothalamic-Pituitary-Ovarian Axis
Open the PDF for in another window
Hypothalamic Response to Kisspeptin-54 and Pituitary Response to Gonadotropin-Releasing Hormone Are Preserved in Healthy Older Men
Ali Abbara; Shakunthala Narayanaswamy; Chioma Izzi-Engbeaya; Alexander N. Comninos; Sophie A. Clarke; Zainab Malik; Deborah Papadopoulou; Ailish Clobentz; Zubair Sarang; Paul Bassett; Channa N. Jayasena; Waljit S. Dhillo
Neuroendocrinology (2018) 106 (4): 401–410. https://doi.org/10.1159/000488452
View articletitled, Hypothalamic Response to Kisspeptin-54 and Pituitary Response to Gonadotropin-Releasing Hormone Are Preserved in Healthy Older Men
Open the PDF for in another window
Contents Vol. 106, 2018
Neuroendocrinology (2018) 106 (4): I–IV. https://doi.org/10.1159/000489904
View articletitled, Contents Vol. 106, 2018
Open the PDF for in another window
The impact of SGLT2 inhibitors on dementia onset in patients with type 2 diabetes - A meta-analysis of cohort studies
Maternal diet and vulnerability to cognitive impairment in adulthood: possible link with Alzheimer’s disease?
Temozolomide treatment in refractory pituitary adenomas and pituitary carcinomas
Survivin as a therapeutic target for neuroendocrine neoplasms
  • Online ISSN 1423-0194
  • Print ISSN 0028-3835
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal